SANTA CLARA, Calif. — Affymetrix, Inc. (NASDAQ:AFFX) announced today that it has been selected as the genotyping supplier by the Green Super Rice project coordinated by the Chinese Academy of Agricultural Sciences as part of their effort to develop, within the next three years, at least fifteen new rice varieties and deliver them to small-hold […]
Oxford, England — Genomics and proteomics-based research and diagnostics company Sengenics today announced its acquisition of Oxford Gene Technology’s (OGT) protein array technology, a patented auto-antibody profiling platform which was spun out from research that was commercialised as a joint collaboration between the University of Oxford and the University of Cambridge in 1996. It is […]
Oxford Gene Technology (OGT), the molecular genetics company, today announces a strategic realignment of its commercial operations to fuel further growth in its high value genomics products portfolio. As part of this realignment, OGT will transfer its next generation sequencing services business to Source BioScience (LSE: SBS). Financial details were not disclosed. Mike Evans, CEO […]
SANTA CLARA, Calif. — Affymetrix, Inc. (Nasdaq:AFFX) has announced three recipients of the 2015 United States Affymetrix Tumor Profiling Grant Program. The grant program, first launched in 2014, is designed to support translational cancer researchers in the discovery and validation of novel diagnostic, prognostic, and therapeutic biomarkers that may address an unmet clinical need. The […]
LEXINGTON, Ky. — The best has just gotten better. Neogen’s Igenity Dairy Heifer Program now features an upgraded Igenity-Elite genomic test that analyzes nearly 150,000 gene markers — the most powerful and complete tool available for official genomic evaluations. Neogen’s improved Igenity-Elite profile produces the most reliable USDA-CDCB genomic evaluation through the use of a […]
Berlin, Germany, and Brisbane, Australia: The project will combine the advantages of the Mix&Go technology with the capability of SCIENION’s precision spotting sciFLEXARRAYER technology, with the objective of delivering more accurate results and better, longer-lasting and more cost effective diagnostics. The first targeted products of the Anteo and SCIENION collaboration will be activated glass and […]
Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s […]
Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s […]
SANTA CLARA, Calif.– Affymetrix, Inc. (NASDAQ:AFFX), BioRealm, LLC, and RUCDR Infinite Biologics today announced a broad strategic alliance. This alliance will leverage BioRealm’s SmokeScreen® platform to genotype the National Institute on Drug Abuse (NIDA) biorepository of more than 50,000 samples, collected from human subjects studied in NIDA-funded research. NIDA preserves these samples in a biorepository […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has signed an agreement to expand its relationship with Illumina (NASDAQ: ILMN), the global leader in sequencing and genomics. Under the agreement, Illumina will market and sell arrays with Neogen’s custom SNP content, built on Illumina Infinium® BeadArray technology, to the global agrigenomics community. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
